Atherogenic dyslipidemia but not total and high molecular weight adiponectin are associated with the prognostic outcome in patients with coronary heart disease

Ähnliche Einträge

• Relationship of adiponectin with markers of systemic inflammation, atherogenic dyslipidemia and heart failure in patients with coronary heart disease
  Veröffentlicht: (2006)
• Adiponectin, risk of coronary heart disease and correlations with cardiovascular risk markers
  Veröffentlicht: (2005)
• Total lipid management and cardiovascular disease in the dyslipidemia international study
  von: Ferrières, Jean, et al.
  Veröffentlicht: (2013)
• Urinary excretion of high molecular weight adiponectin is an independent predictor of decline of renal function in type 2 diabetes
  von: Kopf, Stefan, et al.
  Veröffentlicht: (2014)
• Dyslipidemia in chronic kidney disease: randomized controlled trial of colestilan versus simvastatin in dialysis patients
  Veröffentlicht: (2014)